Csaba Kovesdy

Salem VA Medical Center, United States of America

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Nephrology > Dialysis & Renal Transplantation (since 31 March 2008)

All recent recommendations

• 8.6
  Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.
  Recommended by Kamyar Kalantar-Zadeh, Jurg Schifferli with Michael Mayr, Kenneth White with Emily G Farrow, Bradley Dixon, Csaba Kovesdy, Alan Yu with Jeanie Park
  
• 6.5
  Aliskiren combined with losartan in type 2 diabetes and nephropathy.
  Recommended by Csaba Kovesdy, Jurg Schifferli with Michael Mayr, Rajiv Agarwal
  
• 10.0
  Telmisartan, ramipril, or both in patients at high risk for vascular events.
  Recommended by Csaba Kovesdy, Sripal Bangalore, Enyu Imai, Ernie Esquivel